Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.

@article{Fang2008EfficacyAS,
  title={Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.},
  author={Xiaoyun Fang and Hirokazu Sakaguchi and Fumi Gomi and Yusuke Oshima and Miki Sawa and Motokazu Tsujikawa and Yasushi Ikuno and M. Kamei and Shunji Kusaka and Yasuo Tano},
  journal={Acta ophthalmologica},
  year={2008},
  volume={86 7},
  pages={800-5}
}
PURPOSE To assess the efficacy, duration of effect and safety of one intravitreal injection of bevacizumab in diabetic macular oedema (DMO). METHODS Bevacizumab (1 mg/0.04 ml) was injected intravitreally into eyes with DMO (29 with and nine without previous treatments). Best corrected visual acuity (BCVA), intraocular pressure and central retinal thickness (CRT) were measured; slit-lamp examination, macular biomicroscopy, optical coherence tomography and fluorescein angiography were performed… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Similar Papers

Loading similar papers…